ProCE Banner Activity

The Nephrologist’s Role in Targeting ASCVD Risk Reduction in Patients With CKD

Clinical Thought

The risk of cardiovascular morbidity and mortality is significantly higher in patients with CKD, especially those with late-stage disease. Learn best practices for nephrologists in optimizing overall care for patients with CKD, including how to best address ASCVD risk, as part of the multidisciplinary care team.

Released: June 12, 2024

Expiration: June 11, 2025

Share

Faculty

Mark J. Sarnak

Mark J. Sarnak, MD, MS

Chief, Division of Nephrology
Tufts Medical Center
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC in collaboration with American Kidney Fund.

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Partners

American Kidney Fund

ProCE Banner

Faculty Disclosure

Primary Author

Mark J. Sarnak, MD, MS

Chief, Division of Nephrology
Tufts Medical Center
Professor of Medicine
Tufts University School of Medicine
Boston, Massachusetts

Mark J. Sarnak, MD, MS: consultant/advisor/speaker: Akebia, Boehringer Ingelheim.